文献速递甲状腺与颈部外科

多发性内分泌腺瘤病1型患者初次甲状旁腺切除范围的最优选择:一项Meta分析

Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis.
PubMed 文献 · Surgery · 2020-09-30

结果显示次全切除在复发与持续性甲旁亢方面与全切除相近,且长期甲状旁腺功能减退风险更低。

要点

  • 次全甲状旁腺切除较全切除的长期甲状旁腺功能减退风险更低,复发与持续率相近。
  • 小于次全切除的复发、持续及再手术风险更高,虽长期甲旁减风险更低。
  • MEN1初次甲状旁腺手术宜权衡甲旁减与复发风险,倾向次全切除。

核心结论

  • 次全甲状旁腺切除优于全甲状旁腺切除,复发与持续率相近且长期甲状旁腺功能减退风险更低。
  • 小于次全切除虽降低长期甲旁减风险,但被复发、持续和再手术风险增加所抵消。
  • 未来需针对特定MEN1表型研究小于次全切除,以制定个体化手术方案。

研究设计与样本

  • 全甲状旁腺切除272例,次全甲状旁腺切除510例,小于次全甲状旁腺切除349例。
  • 文献检索采用预先设定的排除标准,比较三种初次手术范围。

主要发现

  • 全切除患者长期甲状旁腺功能减退风险高于次全切除(RR 1.61;95%CI 1.12-2.31;P=.009)。
  • 小于次全切除患者复发风险更高(RR 1.37;95%CI 1.05-1.79;P=.02)。
  • 小于次全切除患者持续性甲旁亢风险更高(RR 2.26;95%CI 1.49-3.41;P=.0001)。
  • 小于次全切除患者因甲旁亢再手术风险更高(RR 2.48;95%CI 1.65-3.73;P<.0001)。
  • 小于次全切除患者长期甲状旁腺功能减退风险更低(RR 0.47;95%CI 0.29-0.75;P=.002)。

临床怎么用

  • MEN1合并原发性甲状旁腺功能亢进初次手术可优先考虑次全甲状旁腺切除,以平衡复发与甲旁减风险。
  • 选择小于次全切除时需告知复发、持续和再手术风险升高。
  • 具体切除范围应结合MEN1表型个体化决策。

局限性

  • 原文未报告纳入研究的偏倚风险、异质性及随访时长等细节。
  • 需未来针对特定MEN1表型开展研究以明确个体化手术方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyperparathyroidism is an almost universal feature of multiple endocrine neoplasia type 1 syndrome. We present a systematic review and meta-analysis of the postoperative outcomes of patients undergoing initial operative treatment of primary hyperparathyroidism complicating multiple endocrine neoplasia 1. METHODS: A comprehensive literature search was performed with a priori defined exclusion criteria for studies comparing total parathyroidectomy, subtotal parathyroidectomy, and less than subtotal parathyroidectomy. RESULTS: Twenty-one studies incorporating 1,131 patients (272 undergoing total parathyroidectomy, 510 subtotal parathyroidectomy, and 349 less than subtotal parathyroidectomy) were identified. Pooled results revealed increased risk for long-term hypoparathyroidism in total parathyroidectomy patients (relative risk 1.61; 95% confidence interval, 1.12-2.31; P = .009) versus those undergoing subtotal parathyroidectomy. In the less than subtotal parathyroidectomy or subtotal parathyroidectomy comparison group, a greater risk for recurrence of hyperparathyroidism (relative risk 1.37; 95% confidence interval, 1.05-1.79; P = .02), persistence of hyperparathyroidism (relative risk 2.26; 95% confidence interval, 1.49-3.41; P = .0001), and reoperation for hyperparathyroidism (relative risk 2.48; 95% confidence interval, 1.65-3.73; P < .0001) was noted for less than subtotal parathyroidectomy patients, albeit with lesser risk for long-term for hypoparathyroidism (relative risk 0.47; 95% confidence interval, 0.29-0.75; P = .002). CONCLUSION: Subtotal parathyroidectomy compares favorably to total parathyroidectomy, exhibiting similar recurrence and persistence rates with a decreased propensity for long-term postoperative hypoparathyroidism. The benefit of the decreased risk of hypoparathyroidism in less than subtotal parathyroidectomy is negated by the increase in the risk for recurrence, persistence, and reoperation. Future studies evaluating the performance of less than subtotal parathyroidectomy in specific multiple endocrine neoplasia 1 phenotypes should be pursued in an effort to delineate a patient-tailored, operative approach that optimizes long-term outcomes.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Nastos C, Papaconstantinou D, Kofopoulos-Lymperis E, et al. Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis. Surgery. 2020. PMID: 33008613. doi:10.1016/j.surg.2020.08.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。